Stocksigma LogoStocksigma Logo

Genpharmasec Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)

■ Revenue: 8,566 (+162.5% YoY | +72.3% QoQ) ■ EBITDA: 164 (Loss to Profit YoY | +71.4% QoQ) ■ EBITDA Margin (%): 1.9 (Loss to Profit YoY | -1 bps QoQ) ■

Genpharmasec Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)

Genpharmasec Ltd · Outcome · 03 Nov 2026, 10:55 pm

Genpharmasec Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) ■ Revenue: 8,566 (+162.5% YoY | +72.3% QoQ) ■ EBITDA: 164 (Loss to Profit YoY | +71.4% QoQ) ■ EBITDA Margin (%): 1.9 (Loss to Profit YoY | -1 bps QoQ) ■ PAT: 125 (Loss to Profit YoY | +381.9% QoQ) ■ EPS (INR): 0.01 (Loss to Profit YoY) Genpharmasec Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) Segmental Performance Pharmaceutical Trading ■ Revenue: 8,155 (+165.5% YoY | +73.5% QoQ) ■ EBIT: 282 (+93.3% YoY | +28.2% QoQ) ■ EBIT Margin (%): 3.5 (-129 bps YoY | -122 bps QoQ) Laboratory Testing ■ Revenue: 0.0 (-100.0% YoY) ■ EBIT: -39.9 (-6.3% YoY | -36.7% QoQ) ■ EBIT Margin (%): 0.0 (Loss to Profit YoY) Manufacturing & Processing ■ Revenue: 411 (+172.5% YoY | +51.3% QoQ) ■ EBIT: -40.0 (+75.8% YoY | +68.0% QoQ) ■ EBIT Margin (%): -9.7 (+9981 bps YoY | +3627 bps QoQ)

Original exchange filing (PDF)

More announcements from Genpharmasec Ltd

All Genpharmasec Ltd announcements